Fabletics’ Efforts in Spreading Breast Cancer Awareness

October is a breast cancer awareness month and many organizations partner with others to spread awareness and support affected women. Fabletics and the Council of Fashion Designers of America (CFDA) have come together to partner with Fashion Targets Breast Cancer (FTBC). FTBC is a UK-based campaign that supports those affected by the disease and funds breast cancer research. The campaign provides grants to help immigrants, minority women affected by cancer and also aid women with breast cancer.

Kate Hudson who is the co-founder of Fabletics will be the FTBC Ambassador. She is well known for advocating for women to live healthy and active lives and thus she is well suited for the position. She will support, empower and spread awareness in the campaign that seeks to combat breast cancer. Fabletics have launched an outfit which includes a pair of Capri leggings, two tank tops and a bralette. The proceeds from the above collection will support the campaign on Facebook. Kate, a health enthusiast, understands how fashion can support charitable acts.

Fabletics is a subsidiary of JustFab Inc., a famous online retailer with other successful brands. The athleisure brand was founded to bridge the gap that was there in the active wear market. The three co-founders are Don Ressler, Adam Goldenberg and Kate Hudson. The Kate Hudson brand as it is known to many, was launched in October 2013. Over the years, it has gained popularity and has shipped over 2.5 Million Orders and has over 1 Million signed members. The VIP members get discounts on purchases while new members buy outfit starting from $25. The brand has new collections every month and members can either shop for $49.95 every month or opt to skip a month. Outfits are of high-quality fabrics, and the prices are more affordable compared to other brands in the market. Fabletics sells personalized athletic outfits that are based on the customer’s preferences.

Though the brand started as an online retailer, in September 2015 it opened six retail stores, and the founders are set to open 75-100 stores in the next few years. The active wear has become trendy and the leggings are Fabletics’ top sellers at https://twitter.com/fabletics. Kate Hudson, an actress and a tastemaker is dedicated to encouraging people to live their passion and the outfits come in handy whether you are in a studio or looking after your children. The athleisure company launched a men’s line, FL2 in June 2015 that sells accessories and men’s apparel. Fabletics is in the process of expansion to include dresses and swimwear in its collection. The company is available in Germany, US, Canada, UK, Australia, Netherlands, Spain and France.

CEO Clay Siegall Expands the Biotech Company Seattle Genetics

The most successful and long lasting biotech company in Bothell, Washington just hiked up their stocks to $552 million. Seattle Genetics chose to do this after a rise in the amount of interest from their numerous investors. The company’s stock closed up on Monday at 4% and at $46.74 a share. The offer closed on September 16, 2015.

The CEO and co-founder of the biotechnology company -Clay Siegall- stated that the company is not expected to make large profits. They want to expand using the extra interest. Their goal is to hire one hundred new employees every year for potentially the upcoming five years. Seattle Genetics also focuses on their drug pipeline and on their successful cancer treatment drugs. Their most successful cancer treating drug to date is the Adcetris.

Clay Siegall holds his position as CEO and co-founder of Seattle Genetics from his education and his past work experiences. He has a PhD. in Genetics and a B.S. in Zoology. He has always focused his scientific studies on cancer research. In the late eighties and early nineties he worked for National Cancer Institute, National Institutes of Health. During the nineties he worked for Bristol-Myers Squibb Pharmaceutical Research Institute. After his time at Bristol-Myers Squibb Pharmaceutical Research Institute he moved on to co-found and become the CEO of Seattle Genetics in 1998. Since the company’s founding he has worked for Seattle Genetics and their development of cancer treatment drugs and other drug research in the hopes to better the health and quality of humanity.

Continue learning about Clay Siegall:

http://www.ultragenyx.com/about/board/siegall/